Ahmedabad-based Torrent Pharmaceuticals net profit for the second quarter of the fiscal was down 1 per cent year-on-year at Rs 312 crore dragged by the performances in US and German markets.
The consolidated revenues of Torrent Pharma were up 7 per cent Rs 2,291 crore. The earnings before interest, tax, depreciation and amortization (Ebitda) of Rs 694 crore was down by 2 per cent, with a resulting Ebitda margin of 30 per cent. Half yearly revenues grew 9 per cent to Rs 4,638 crore, with a PAT of Rs 666 crore, up 3 per cent.
The India-focussed company did well in the